Northwest Biotherapeutics Market Cap

Northwest Biotherapeutics has a market cap or net worth of $317.24 million as of April 28, 2026. Its market cap has increased by 16.70% in one year.

Market Cap

317.24M

Enterprise Value

391.73M

Revenue

1.38M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.20

Market Cap Chart

Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 317.24M, an increase of 2,983.18%. That is a compound annual growth rate of 15.10%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	317.24M	-11.48%
Dec 31, 2025	358.39M	-1.53%
Dec 31, 2024	363.95M	-55.71%
Dec 29, 2023	821.84M	-1.00%
Dec 30, 2022	830.10M	25.14%
Dec 31, 2021	663.34M	-47.13%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Silence Therapeutics	369.37M
CytoDyn	436.45M
Vaxart	187.80M
Glorywin Entertainment Group	149.60M
NDT Pharmaceuticals	110.32M
Viskase Holdings	93.59M
BioStem Technologies	78.01M
HST Global	63.64M

Market Cap Rankings